Articles with public access mandates - Matthew FriemanLearn more
Not available anywhere: 3
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
T Luke, H Wu, J Zhao, R Channappanavar, CM Coleman, JA Jiao, ...
Science translational medicine 8 (326), 326ra21-326ra21, 2016
Mandates: US Department of Energy, US National Institutes of Health
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection
RE Haupt, EM Harberts, RJ Kitz, S Strohmeier, F Krammer, RK Ernst, ...
Vaccine 39 (36), 5205-5213, 2021
Mandates: US Department of Defense, US National Institutes of Health
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreño, VM Corman, ...
Science translational medicine 16 (747), eadl1722, 2024
Mandates: Swiss National Science Foundation, Bill & Melinda Gates Foundation, Austrian …
Available somewhere: 134
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
J Hansen, A Baum, KE Pascal, V Russo, S Giordano, E Wloga, BO Fulton, ...
Science 369 (6506), 1010-1014, 2020
Mandates: US National Institutes of Health, US Assistant Secretary for Preparedness …
Animal models for COVID-19
C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ...
Nature 586 (7830), 509-515, 2020
Mandates: US National Institutes of Health
Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles
P Moitra, M Alafeef, K Dighe, MB Frieman, D Pan
ACS nano 14 (6), 7617-7627, 2020
Mandates: US National Institutes of Health
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection
J Dyall, CM Coleman, BJ Hart, T Venkataraman, MR Holbrook, ...
Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014
Mandates: US National Institutes of Health
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ...
Science 370 (6521), eabe9403, 2020
Mandates: US National Science Foundation, Bill & Melinda Gates Foundation, US …
Bats and coronaviruses
A Banerjee, K Kulcsar, V Misra, M Frieman, K Mossman
Viruses 11 (1), 41, 2019
Mandates: US National Institutes of Health, Natural Sciences and Engineering Research …
Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis
J Kindrachuk, B Ork, BJ Hart, S Mazur, MR Holbrook, MB Frieman, ...
Antimicrobial agents and chemotherapy 59 (2), 1088-1099, 2015
Mandates: US Department of Energy, US National Institutes of Health
Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-κB signaling
M Frieman, K Ratia, RE Johnston, AD Mesecar, RS Baric
Journal of virology 83 (13), 6689-6705, 2009
Mandates: US National Institutes of Health
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
KA Kulcsar, CM Coleman, SE Beck, MB Frieman
JCI insight 4 (20), e131774, 2019
Mandates: US National Institutes of Health
Evidence supporting a zoonotic origin of human coronavirus strain NL63
J Huynh, S Li, B Yount, A Smith, L Sturges, JC Olsen, J Nagel, ...
Journal of virology 86 (23), 12816-12825, 2012
Mandates: US National Institutes of Health
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
L Si, H Bai, M Rodas, W Cao, CY Oh, A Jiang, R Moller, D Hoagland, ...
Nature biomedical engineering 5 (8), 815-829, 2021
Mandates: Bill & Melinda Gates Foundation, US Department of Defense, US National …
Insights from nanomedicine into chloroquine efficacy against COVID-19
TY Hu, M Frieman, J Wolfram
Nature nanotechnology 15 (4), 247-249, 2020
Mandates: US Department of Defense, US National Institutes of Health
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
CM Coleman, YV Liu, H Mu, JK Taylor, M Massare, DC Flyer, GM Glenn, ...
Vaccine 32 (26), 3169-3174, 2014
Mandates: US National Institutes of Health
Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion
CM Coleman, JM Sisk, RM Mingo, EA Nelson, JM White, MB Frieman
Journal of virology 90 (19), 8924-8933, 2016
Mandates: US National Institutes of Health
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ...
Nature microbiology 6 (10), 1233-1244, 2021
Mandates: US Department of Energy, US Department of Defense, US National Institutes of …
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
BJ Hart, J Dyall, E Postnikova, H Zhou, J Kindrachuk, RF Johnson, ...
Journal of general virology 95 (3), 571-577, 2014
Mandates: US National Institutes of Health
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling
X Peng, L Gralinski, CD Armour, MT Ferris, MJ Thomas, S Proll, ...
MBio 1 (5), 10.1128/mbio. 00206-10, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program